AMPH (Amphastar Pharmaceuticals Inc) Yalpi foyda normasi

Amphastar Pharmaceuticals Inc (AMPH) korporativ emblemasi va logotipi

Amphastar Pharmaceuticals (AMPH) o'zining inyeksion mahsulotlar liniyalari bo'yicha barqaror tijorat o'sishini namoyish etmoqda. GURU.Markets platformasidagi grafikni tahlil qilib, umumiy yalpi foyda 44.70 darajasida saqlanayotganini ko'rishimiz mumkin. Bu B2B bozori uchun shoshilinch generiklar sektoridagi kompaniyaning yetakchiligi bilan bog'liq. Yuqori samaradorlikka esa ixtisoslashtirilgan respirator terapiya dori vositalari va tibbiy sarflanadigan materiallar savdosi orqali erishilmoqda.

Amphastar Pharmaceuticals, Inc. (AMPH) Yalpi rentabellik: 04.07.2022 - 20.11.2026 davri uchun

Amphastar Corp (AMPH) moliyaviy va bozor koʻrsatkichlari kesimi

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Amphastar (AMPH)
Amphastar yetakchi tovari

Generic inhalatorlarni ishlab chiqarishning murakkabligi va FDA ning qat'iy nazorati Amphastar Pharmaceuticals (AMPH) kompaniyasiga yuqori bozor barqarorligini ta'minlaydi. Kompaniyaning yalpi marjasi bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini aks ettiradi, bu esa investorlarga xomashyo xarajatlarini boshqarish samaradorligini baholash imkonini beradi. Ushbu ko'rsatkichni monitoring qilish foydalilikning yashirin ravishda kamayishini oldindan aniqlashga yordam beradi va kompaniyaning yalpi marjasini tahlil qilishda aktiv uchun haddan tashqari ko'p to'lov qilishning oldini oladi.

Muhim raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|Pacira Pharmaceuticals (PCRX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja SPRY|TBPH - Yalpi foyda marjasi|Aquestive Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi marja scpharmaceuticals.com SCPH|Tectonic - Yalpi marja|TNXP - Yalpi marja|SXTC: Yalpi marja|Eupraxia Pharma - Yalpi foyda normasi|BHST (bioharvest.com) - Yalpi marja|Sotuvning yalpi rentabelligi EXOZ (invizyne.com)|Yalpi marja ORMP|Yalpi foyda bo'yicha sotuv rentabelligi Entera Bio|Yalpi marja HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Yalpi rentabellik|Cumberland Corp - Yalpi marja|QNTM - Yalpi marja|FibroGen, Inc. (FGEN) - Yalpi rentabellik|TELO: Yalpi foyda koeffitsiyenti|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja